ALCAM and neoplasm: Our group has described several cellular adhesion molecules specifically upregulated within the tumor-associated microglial population (Soto et al., 2014, 2016), and inhibition of tumorigenic molecules such as lymphocyte function-associated antigen 1 (LFA-1) and activated leukocyte cellular adhesion molecule (ALCAM) have been shown to significantly reduce breast cancer BM.